MedPageToday -- BOSTON -- A novel flu vaccine -- based on virus-like particles (VLPs) produced in recombinant insect cells -- induced strong antibody responses in two phase II clinical studies, researchers reported here.
MedPageToday -- BOSTON -- A novel flu vaccine -- based on virus-like particles (VLPs) produced in recombinant insect cells -- induced strong antibody responses in two phase II clinical studies, researchers reported here.